Promise of endothelial progenitor cell for treatment of diabetic retinopathy

References

• Fong DS, Sharza M, Chen W, Paschal JF, Ariyasu RG, Lee PP. Vision loss among diabetics in a group model health maintenance organization (HMO). Am. J. Ophthalmol.133(2), 236–241 (2002).
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology98(5 Suppl.), 766–785 (1991).
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group.Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch. Ophthalmol.113(9), 1144–1155 (1995).
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T. Isolation of putative progenitor endothelial cells for angiogenesis. Science275, 964–967 (1997).
   PubMed Web of Science ®Google Scholar
• Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood105(7), 2783–2786 (2005).
   PubMed Web of Science ®Google Scholar
• Grant MB, May WS, Caballero S et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med.8(6), 607–612 (2002).
   PubMed Web of Science ®Google Scholar
• Bailey AS, Jiang S, Afentoulis M et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood103(1), 13–19 (2004).
   PubMed Web of Science ®Google Scholar
• Loomans CJ, Van Haperen R, Duijs JM et al. Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia. Mol. Med.15(5–6), 152–159 (2009).
   PubMed Web of Science ®Google Scholar
• Case J, Ingram DA, Haneline LS. Oxidative stress impairs endothelial progenitor cell function. Antioxid. Redox Signal.10(11), 1895–1907 (2008).
   PubMed Web of Science ®Google Scholar
• Loomans CJ, De Koning EJ, Staal FJ et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of Type 1 diabetes. Diabetes53(1), 195–199 (2004).
   PubMed Web of Science ®Google Scholar
• Funada J, Sekiya M, Hamada M, Hiwada K. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction. Circ. J.66(2), 127–132 (2002).
   PubMed Web of Science ®Google Scholar
• Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin. Exp. Pharmacol. Physiol.31(7), 407–413 (2004).
   PubMed Web of Science ®Google Scholar
• Zhu J, Xu ZK, Miao Y, Liu XL, Zhang H. Changes of inducible protein-10 and regulated upon activation, normal t cell expressed and secreted protein in acute rejection of pancreas transplantation in rats. World J. Gastroenterol.12(26), 4156–4160 (2006).
   PubMedGoogle Scholar
• Tamarat R, Silvestre JS, Le Ricousse-Roussanne S et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am. J. Pathol.164(2), 457–466 (2004).
   PubMed Web of Science ®Google Scholar
• Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes50(7), 1636–1642 (2001).
   PubMed Web of Science ®Google Scholar
• Caballero S, Sengupta N, Afzal A et al. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes56(4), 960–967 (2007).
   PubMed Web of Science ®Google Scholar
• Fadini GP, Sartore S, Baesso I et al. Endothelial progenitor cells and the diabetic paradox. Diabetes Care29(3), 714–716 (2006).
   PubMedGoogle Scholar
• Lee IG, Chae SL, Kim JC. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. Eye (Lond.)20(5), 546–552 (2006).
   PubMedGoogle Scholar
• Rafat N, Beck GC, Schulte J, Tuettenberg J, Vajkoczy P. Circulating endothelial progenitor cells in malignant gliomas. J. Neurosurg. (2009) (Epub ahead of print).
   Google Scholar
• Gehling UM, Ergun S, Schumacher U et al.In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood95(10), 3106–3112 (2000).
   PubMed Web of Science ®Google Scholar
• Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest.105(1), 71–77 (2000).
   PubMed Web of Science ®Google Scholar
• Gulati R, Jevremovic D, Peterson TE et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res.93(11), 1023–1025 (2003).
   PubMed Web of Science ®Google Scholar
• Gulati R, Jevremovic D, Peterson TE et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation108(12), 1520–1526 (2003).
   PubMed Web of Science ®Google Scholar
• Asahara T, Takahashi T, Masuda H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J.18(14), 3964–3972 (1999).
   PubMed Web of Science ®Google Scholar
• Wijelath ES, Murray J, Rahman S et al. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ. Res.91(1), 25–31 (2002).
   PubMed Web of Science ®Google Scholar
• Eggermann J, Kliche S, Jarmy G et al. Endothelial progenitor cell culture and differentiation In vitro: a methodological comparison using human umbilical cord blood. Cardiovasc. Res.58(2), 478–486 (2003).
   PubMed Web of Science ®Google Scholar
• Fernandez Pujol B, Lucibello FC, Gehling UM et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation65(5), 287–300 (2000).
   PubMedGoogle Scholar
• Hur J, Yoon CH, Kim HS et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol.24(2), 288–293 (2004).
   PubMed Web of Science ®Google Scholar
• Delorme B, Basire A, Gentile C et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb. Haemost.94(6), 1270–1279 (2005).
   PubMed Web of Science ®Google Scholar
• Crosby JR, Kaminski WE, Schatteman G et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ. Res.87(9), 728–730. (2000).
   PubMed Web of Science ®Google Scholar
• Yoon CH, Hur J, Park KW et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation112(11), 1618–1627 (2005).
   PubMed Web of Science ®Google Scholar
• Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am. J. Physiol. Heart Circ. Physiol.292(1), H1–H18 (2007).
   Google Scholar
• Kalka C, Masuda H, Takahashi T et al. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res.86(12), 1198–1202. (2000).
   PubMed Web of Science ®Google Scholar
• Harraz M, Jiao C, Hanlon HD, Hartley RS, Schatteman GC. CD34- blood-derived human endothelial cell progenitors. Stem Cells19(4), 304–312 (2001).
   PubMed Web of Science ®Google Scholar
• Romagnani P, Annunziato F, Liotta F et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ. Res.97(4), 314–322 (2005).
   PubMed Web of Science ®Google Scholar
• Awad O, Dedkov EI, Jiao C, Bloomer S, Tomanek RJ, Schatteman GC. Differential healing activities of CD34+ and CD14+ endothelial cell progenitors. Arterioscler. Thromb. Vasc. Biol.26(4), 758–764 (2006).
   PubMed Web of Science ®Google Scholar
• Cho HJ, Kim HS, Lee MM et al. Mobilized endothelial progenitor cells by granulocyte–macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation108(23), 2918–2925 (2003).
   PubMed Web of Science ®Google Scholar
• George J, Herz I, Goldstein E et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler. Thromb. Vasc. Biol.23(12), e57–e60 (2003).
   PubMed Web of Science ®Google Scholar
• Ghani U, Shuaib A, Salam A et al. Endothelial progenitor cells during cerebrovascular disease. Stroke36(1), 151–153 (2005).
   PubMed Web of Science ®Google Scholar
• Loomans CJ, Wan H, De Crom R et al. Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial no synthase expression. Arterioscler. Thromb. Vasc. Biol.26(8), 1760–1767 (2006).
   PubMed Web of Science ®Google Scholar
• Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension45(3), 321–325 (2005).
   PubMed Web of Science ®Google Scholar
• Heissig B, Hattori K, Dias S et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell109(5), 625–637 (2002).
   PubMed Web of Science ®Google Scholar
• Heissig B, Werb Z, Rafii S, Hattori K. Role of c-kit/kit ligand signaling in regulating vasculogenesis. Thromb. Haemost.90(4), 570–576 (2003).
   PubMedGoogle Scholar
• Shintani S, Murohara T, Ikeda H et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation103(6), 897–903 (2001).
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by AKT-dependent phosphorylation. Nature399(6736), 601–605. (1999).
   PubMed Web of Science ®Google Scholar
• Sorrentino SA, Bahlmann FH, Besler C et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with Type 2 diabetes mellitus: Restoration by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation116(2), 163–173 (2007).
   PubMed Web of Science ®Google Scholar
• Thum T, Fraccarollo D, Schultheiss M et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes56(3), 666–674 (2007).
   PubMed Web of Science ®Google Scholar
• Vasa M, Breitschopf K, Zeiher AM, Dimmeler S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ. Res.87(7), 540–542 (2000).
   PubMed Web of Science ®Google Scholar
• Li Calzi S, Purich DL, Chang KH et al. Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein (VASP) phosphorylation: evidence for blunted responsiveness in diabetes. Diabetes57(9), 2488–2494 (2008).
   PubMed Web of Science ®Google Scholar
• Segal MS, Shah R, Afzal A et al. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes55(1), 102–109 (2006).
   PubMedGoogle Scholar
• Chang KH, Chan-Ling T, Mcfarland EL et al. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc. Natl Acad. Sci. USA104(25), 10595–10600 (2007).
   PubMed Web of Science ®Google Scholar
• Ma FX, Zhou B, Chen Z et al. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J. Lipid Res.47(6), 1227–1237 (2006).
   PubMed Web of Science ®Google Scholar
• Shin T, Weinstock D, Castro MD et al. Immunohistochemical localization of endothelial and inducible nitric oxide synthase within neurons of cattle with rabies. J. Vet. Med. Sci.66(5), 539–541 (2004).
   PubMedGoogle Scholar
• Stadler K, Bonini MG, Dallas S, Duma D, Mason RP, Kadiiska MB. Direct evidence of inos-mediated in vivo free radical production and protein oxidation in acetone-induced ketosis. Am. J. Physiol. Endocrinol. Metab.295(2), E456–462 (2008).
   Google Scholar
• Leal EC, Manivannan A, Hosoya K et al. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood–retinal barrier breakdown in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci.48(11), 5257–5265 (2007).
   PubMed Web of Science ®Google Scholar
• Nagareddy PR, Xia Z, Mcneill JH, Macleod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am. J. Physiol. Heart Circ. Physiol.289(5), H2144–H2152 (2005).
   Google Scholar
• Cheng X, Cheng XS, Kuo KH, Pang CC. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes. Cardiovasc. Res.64(2), 298–307 (2004).
   PubMedGoogle Scholar
• Ellis EA, Guberski DL, Hutson B, Grant MB. Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide6(3), 295–304 (2002).
   PubMed Web of Science ®Google Scholar
• Szabo C, Mabley JG, Moeller SM et al. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol. Med.8(10), 571–580 (2002).
   PubMedGoogle Scholar
• Kobayashi T, Taguchi K, Takenouchi Y, Matsumoto T, Kamata K. Insulin-induced impairment via peroxynitrite production of endothelium-dependent relaxation and sarco/endoplasmic reticulum Ca2+-ATPase function in aortas from diabetic rats. Free Radic. Biol. Med.43(3), 431–443 (2007).
   PubMed Web of Science ®Google Scholar
• Camici GG, Schiavoni M, Francia P et al. Genetic deletion of p66(shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc. Natl Acad. Sci. USA104(12), 5217–5222 (2007).
   PubMed Web of Science ®Google Scholar
• Sasaki N, Yamashita T, Takaya T et al. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus. Arterioscler. Thromb. Vasc. Biol.28(6), 1068–1076 (2008).
   PubMed Web of Science ®Google Scholar
• Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest.95(1), 187–194 (1995).
   PubMed Web of Science ®Google Scholar
• Gao J, Zhao WX, Zhou LJ et al. Protective effects of propofol on lipopolysaccharide-activated endothelial cell barrier dysfunction. Inflamm. Res.55(9), 385–392 (2006).
   PubMed Web of Science ®Google Scholar
• Luo T, Xia Z, Ansley DM et al. Propofol dose-dependently reduces tumor necrosis factor-α-induced human umbilical vein endothelial cell apoptosis: Effects on Bcl-2 and Bax expression and nitric oxide generation. Anesth. Analg.100(6), 1653–1659 (2005).
   PubMed Web of Science ®Google Scholar
• Chen YS, Chen KH, Liu CC et al. Propofol-induced vascular permeability change is related to the nitric oxide signaling pathway and occludin phosphorylation. J. Biomed. Sci.14(5), 629–636 (2007).
   PubMedGoogle Scholar
• Sasaki K, Heeschen C, Aicher A et al.Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc. Natl Acad. Sci. USA103(39), 14537–14541 (2006).
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Aicher A, Vasa M et al. HMG-COA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/AKT pathway. J. Clin. Invest.108(3), 391–397. (2001).
   PubMed Web of Science ®Google Scholar
• Landmesser U, Engberding N, Bahlmann FH et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation110(14), 1933–1939 (2004).
   PubMed Web of Science ®Google Scholar
• Verma S, Szmitko PE, Anderson TJ. Endothelial function: Ready for prime time? Can. J. Cardiol.20(13), 1335–1339 (2004).
   PubMedGoogle Scholar
• Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation113(13), 1708–1714 (2006).
   PubMed Web of Science ®Google Scholar
• Thum T, Bauersachs J. Spotlight on endothelial progenitor cell inhibitors: short review. Vasc. Med.10(Suppl. 1), S59–S64 (2005).
   PubMedGoogle Scholar
• Achan V, Broadhead M, Malaki M et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler. Thromb. Vasc. Biol.23(8), 1455–1459 (2003).
   PubMed Web of Science ®Google Scholar
• Dayoub H, Achan V, Adimoolam S et al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation108(24), 3042–3047 (2003).
   PubMed Web of Science ®Google Scholar
• Busik JV, Tikhonenko M, Bhatwadekar A, Opreanu M et al. Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J. Exp. Med. DOI: jem.20090889v1-jem.20090889 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature460(7252), 259–263 (2009).
   PubMed Web of Science ®Google Scholar
• Digman C, Borto D, Nasraway SA Jr. Hyperglycemia in the critically ill. Nutr. Clin. Care8(2), 93–101 (2005).
   PubMedGoogle Scholar
• Maaravi Y, Stessman J. Mild, reversible pancytopenia induced by rosiglitazone. Diabetes Care28(6), 1536 (2005).
   PubMedGoogle Scholar
• Berria R, Glass L, Mahankali A et al. Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus. Clin. Pharmacol. Ther.82(3), 275–281 (2007).
   PubMed Web of Science ®Google Scholar
• Lazarenko OP, Rzonca SO, Hogue WR, Swain FL, Suva LJ, Lecka-Czernik B. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology148(6), 2669–2680 (2007).
   PubMed Web of Science ®Google Scholar
• Khan SS, Solomon MA, Mccoy JP Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin. Cytom.64(1), 1–8 (2005).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur. Heart J.27(23), 2775–2783 (2006).
   PubMed Web of Science ®Google Scholar
• Erbs S, Linke A, Schachinger V et al. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler substudy of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction (REPAIR-AMI) trial. Circulation116(4), 366–374 (2007).
   PubMed Web of Science ®Google Scholar